Want to see HK:1518 full AI Analyst Report?
New Century Healthcare Holding Co. Ltd. (1518) Ratios
New Century Healthcare Holding Co. Ltd. Ratios
HK:1518's free cash flow for Q2 2026 was $-216.56M. For the 2026 fiscal year, HK:1518's free cash flow was decreased by $-1.19M and operating cash flow was $-215.37M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.29 | 1.58 | 1.32 | 1.03 | 1.58 |
| Quick Ratio | 1.24 | 1.52 | 1.25 | 0.95 | 1.51 |
| Cash Ratio | 0.83 | 1.21 | 0.91 | 0.68 | 0.77 |
| Solvency Ratio | -0.17 | 0.18 | 0.29 | -0.42 | -0.03 |
| Operating Cash Flow Ratio | 0.06 | 0.47 | 0.47 | 0.23 | 0.08 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -34.50M | $ 30.16M | $ -49.15M | $ -196.39M | $ -125.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.20 | 0.22 | 0.24 | 0.22 |
| Debt-to-Equity Ratio | 0.39 | 0.34 | 0.39 | 0.50 | 0.38 |
| Debt-to-Capital Ratio | 0.28 | 0.25 | 0.28 | 0.33 | 0.28 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.74 | 1.70 | 1.81 | 2.06 | 1.72 |
| Debt Service Coverage Ratio | 0.90 | 16.16 | 24.83 | -16.21 | 1.10 |
| Interest Coverage Ratio | -10.89 | 18.66 | 21.32 | -21.38 | -3.14 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.36 | 0.40 | 0.44 | 0.48 | 0.61 |
| Net Debt to EBITDA | -2.10 | -0.99 | -0.42 | 0.04 | 1.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.31% | 40.75% | 43.63% | 31.76% | 31.42% |
| EBIT Margin | -2.87% | 16.86% | 18.67% | -43.96% | -7.09% |
| EBITDA Margin | 5.07% | 20.16% | 25.10% | -32.92% | 6.60% |
| Operating Profit Margin | -11.83% | 16.77% | 18.41% | -43.78% | -7.09% |
| Pretax Profit Margin | -12.42% | 16.72% | 17.81% | -45.54% | -9.35% |
| Net Profit Margin | -19.22% | 5.60% | 9.02% | -46.78% | -16.04% |
| Continuous Operations Profit Margin | -16.52% | 11.08% | 14.16% | -45.81% | -13.48% |
| Net Income Per EBT | 154.69% | 33.47% | 50.66% | 102.72% | 171.54% |
| EBT Per EBIT | 104.98% | 99.70% | 96.70% | 104.02% | 131.88% |
| Return on Assets (ROA) | -15.46% | 5.04% | 8.91% | -33.03% | -7.98% |
| Return on Equity (ROE) | -26.88% | 8.55% | 16.11% | -67.93% | -13.76% |
| Return on Capital Employed (ROCE) | -15.18% | 21.95% | 28.24% | -49.09% | -4.58% |
| Return on Invested Capital (ROIC) | -13.19% | 13.33% | 20.53% | -46.17% | -4.41% |
| Return on Tangible Assets | -21.48% | 6.74% | 12.01% | -45.71% | -11.83% |
| Earnings Yield | -40.26% | 10.44% | 21.36% | -146.89% | -22.81% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.60 | 11.68 | 11.92 | 10.22 | 3.64 |
| Payables Turnover | 17.25 | 16.76 | 12.86 | 10.91 | 15.81 |
| Inventory Turnover | 33.23 | 32.05 | 23.63 | 17.45 | 20.52 |
| Fixed Asset Turnover | 3.75 | 3.79 | 3.89 | 2.18 | 1.64 |
| Asset Turnover | 0.80 | 0.90 | 0.99 | 0.71 | 0.50 |
| Working Capital Turnover Ratio | 4.85 | 6.14 | 15.90 | 7.07 | 3.04 |
| Cash Conversion Cycle | 16.66 | 20.86 | 17.70 | 23.20 | 95.08 |
| Days of Sales Outstanding | 26.83 | 31.25 | 30.62 | 35.73 | 100.39 |
| Days of Inventory Outstanding | 10.98 | 11.39 | 15.45 | 20.91 | 17.79 |
| Days of Payables Outstanding | 21.15 | 21.77 | 28.38 | 33.45 | 23.09 |
| Operating Cycle | 37.81 | 42.64 | 46.07 | 56.64 | 118.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.04 | 0.28 | 0.33 | 0.16 | 0.05 |
| Free Cash Flow Per Share | 0.02 | 0.24 | 0.31 | 0.14 | 0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.88 | 3.54 | 12.84 | 7.53 | 1.69 |
| Capital Expenditure Coverage Ratio | 1.86 | 6.23 | 14.83 | 7.53 | 1.69 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.73 | 0.77 | 0.35 | 0.08 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.16 | 0.17 | 0.12 | 0.04 |
| Free Cash Flow Yield | 2.89% | 25.14% | 37.61% | 32.64% | 2.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.47 | 9.58 | 4.68 | -0.68 | -4.38 |
| Price-to-Sales (P/S) Ratio | 0.48 | 0.54 | 0.42 | 0.32 | 0.70 |
| Price-to-Book (P/B) Ratio | 0.67 | 0.82 | 0.75 | 0.46 | 0.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 34.57 | 3.98 | 2.66 | 3.06 | 48.88 |
| Price-to-Operating Cash Flow Ratio | 15.97 | 3.34 | 2.48 | 2.66 | 19.99 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.23 | -0.04 | -0.00 | 0.06 |
| Enterprise Value Multiple | 7.31 | 1.67 | 1.26 | -0.92 | 12.00 |
| Enterprise Value | 222.39M | 285.12M | 295.80M | 193.62M | 501.20M |
| EV to EBITDA | 7.31 | 1.67 | 1.26 | -0.92 | 12.00 |
| EV to Sales | 0.37 | 0.34 | 0.32 | 0.30 | 0.79 |
| EV to Free Cash Flow | 26.84 | 2.50 | 2.00 | 2.93 | 55.08 |
| EV to Operating Cash Flow | 12.40 | 2.10 | 1.86 | 2.54 | 22.52 |
| Tangible Book Value Per Share | 0.30 | -0.22 | 0.43 | 0.23 | 0.56 |
| Shareholders’ Equity Per Share | 0.89 | 1.15 | 1.08 | 0.91 | 1.53 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.33 | 0.34 | 0.20 | -0.01 | -0.44 |
| Revenue Per Share | 1.24 | 1.75 | 1.93 | 1.32 | 1.31 |
| Net Income Per Share | -0.24 | 0.10 | 0.17 | -0.62 | -0.21 |
| Tax Burden | 1.55 | 0.33 | 0.51 | 1.03 | 1.72 |
| Interest Burden | 4.32 | 0.99 | 0.95 | 1.04 | 1.32 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 |
| SG&A to Revenue | 0.31 | 0.23 | 0.14 | 0.21 | 0.25 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.24 | 0.96 | 0.96 | -0.26 | -0.38 |
Currency in CNY